| dc.contributor.author | Pamba HO. | |
| dc.contributor.author | Bwibo NO. | |
| dc.contributor.author | Chunge CN. | |
| dc.contributor.author | Estambale, Benson B. | |
| dc.date.accessioned | 2013-04-16T06:11:28Z | |
| dc.date.available | 2013-04-16T06:11:28Z | |
| dc.date.issued | 1989 | |
| dc.identifier.citation | East Afr Med J. 1989 Mar;66(3):197-202 | en |
| dc.identifier.uri | http://www.ncbi.nlm.nih.gov/pubmed/2591328 | |
| dc.identifier.uri | http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/16055 | |
| dc.description.abstract | One hundred children comprising of 57 males and 43 females aged between 8 and 24 months entered the study. 46 children had single and 54 children had multiple helminth infections. All children received albendazole 200 mg (10 ml) suspension as a single dose. Albendazole proved very effective and safe in the treatment of single and multiple helminth infections in children under 2 years of age, achieving cure rates of 100% in both Ascaris lumbricoides and Necator americanus respectively, 83% in Trichuris trichiura and 66% in Hymenolepis nana. Treatment of polyparasitism appears to be of benefit in improving nutritional status using haemoglobin concentrations as an index | en |
| dc.language.iso | en | en |
| dc.title | A study of the efficacy and safety of albendazole (Zentel) in the treatment of intestinal helmenthiasis in Kenyan children less than 2 years of age | en |
| dc.type | Article | en |
| local.publisher | Department of Medical Microbiology, University of Nairobi | en |
| local.publisher | Department of Paediatrics and Child Health, University of Nairobi | en |
